These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 26418829)
41. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth. Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580 [TBL] [Abstract][Full Text] [Related]
42. Development and characterisation of chitosan nanoparticles for siRNA delivery. Katas H; Alpar HO J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358 [TBL] [Abstract][Full Text] [Related]
43. Enhanced antitumor efficacies of multifunctional nanocomplexes through knocking down the barriers for siRNA delivery. Han L; Tang C; Yin C Biomaterials; 2015 Mar; 44():111-21. PubMed ID: 25617131 [TBL] [Abstract][Full Text] [Related]
44. Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers. Raja MA; Katas H; Jing Wen T PLoS One; 2015; 10(6):e0128963. PubMed ID: 26068222 [TBL] [Abstract][Full Text] [Related]
45. GABA Ni S; Liu Y; Tang Y; Chen J; Li S; Pu J; Han L Carbohydr Polym; 2018 Jan; 179():135-144. PubMed ID: 29111036 [TBL] [Abstract][Full Text] [Related]
47. Ternary polymeric nanoparticles for oral siRNA delivery. Zhang J; He C; Tang C; Yin C Pharm Res; 2013 May; 30(5):1228-39. PubMed ID: 23307349 [TBL] [Abstract][Full Text] [Related]
48. Influence of particle size on the in vitro and in vivo anti-inflammatory and anti-allergic activities of a curcumin lipid nanoemulsion. Onodera T; Kuriyama I; Andoh T; Ichikawa H; Sakamoto Y; Lee-Hiraiwa E; Mizushina Y Int J Mol Med; 2015 Jun; 35(6):1720-8. PubMed ID: 25891482 [TBL] [Abstract][Full Text] [Related]
49. Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis. Chen SQ; Song YQ; Wang C; Tao S; Yu FY; Lou HY; Hu FQ; Yuan H Carbohydr Polym; 2020 Feb; 230():115613. PubMed ID: 31887935 [TBL] [Abstract][Full Text] [Related]
50. In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles. Liu Y; Di Zang H; Kong M; Ma FK; Dang QF; Cheng XJ; Ji QX; Chen XG Carbohydr Polym; 2012 Jun; 89(2):453-60. PubMed ID: 24750743 [TBL] [Abstract][Full Text] [Related]
51. Cytoplasm-responsive nanocarriers conjugated with a functional cell-penetrating peptide for systemic siRNA delivery. Tanaka K; Kanazawa T; Horiuchi S; Ando T; Sugawara K; Takashima Y; Seta Y; Okada H Int J Pharm; 2013 Oct; 455(1-2):40-7. PubMed ID: 23911914 [TBL] [Abstract][Full Text] [Related]
52. Down-regulation of TNF-alpha by small interfering RNA inhibits particle-induced inflammation in vitro. Qin CQ; Ding Y; Huang DS; Xu J; Ma RF; Huang JB Artif Organs; 2011 Jul; 35(7):706-14. PubMed ID: 21501190 [TBL] [Abstract][Full Text] [Related]
53. Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties. de Souza RHFV; Picola IPD; Shi Q; Petrônio MS; Benderdour M; Fernandes JC; Lima AMF; Martins GO; Martinez Junior AM; de Oliveira Tiera VA; Tiera MJ Int J Biol Macromol; 2018 Nov; 119():186-197. PubMed ID: 30031084 [TBL] [Abstract][Full Text] [Related]
55. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles. Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321 [TBL] [Abstract][Full Text] [Related]
56. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model. Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978 [TBL] [Abstract][Full Text] [Related]
57. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro. Zhen G; Hinton TM; Muir BW; Shi S; Tizard M; McLean KM; Hartley PG; Gunatillake P Mol Pharm; 2012 Sep; 9(9):2450-7. PubMed ID: 22794355 [TBL] [Abstract][Full Text] [Related]
58. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing. Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703 [TBL] [Abstract][Full Text] [Related]
59. Anti-Inflammatory Effect of Anti-TNF-α SiRNA Cationic Phosphorus Dendrimer Nanocomplexes Administered Intranasally in a Murine Acute Lung Injury Model. Bohr A; Tsapis N; Andreana I; Chamarat A; Foged C; Delomenie C; Noiray M; El Brahmi N; Majoral JP; Mignani S; Fattal E Biomacromolecules; 2017 Aug; 18(8):2379-2388. PubMed ID: 28639789 [TBL] [Abstract][Full Text] [Related]
60. Nanocapsule-mediated cytosolic siRNA delivery for anti-inflammatory treatment. Jiang Y; Hardie J; Liu Y; Ray M; Luo X; Das R; Landis RF; Farkas ME; Rotello VM J Control Release; 2018 Aug; 283():235-240. PubMed ID: 29883695 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]